| 產(chǎn)品名稱(chēng) |
Rotavirus reassortant |
| 商品貨號 |
B163256 |
| Classification |
Reoviridae, Rotavirus |
| Agent |
Rotavirus reassortant |
| Strain |
HD/BRV-1 clone 47-1-1 |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Parent viruses (a) human origin strain from child hospitalized with diarrhea and (b) bovine origin strain UK from calf with diarrhea |
| Product Format |
frozen |
| Storage Conditions |
-60°C |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
Shares the characteristics of other members of the rotavirus family. Shares the characteristics of other members of the rotavirus family. |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects (typical rotavirus CPE) in MA104 in vivo effects: unknown effect in vivo |
| Name of Depositor |
NIH/NIAID |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Parent viruses (a) human origin strain from child hospitalized with diarrhea and (b) bovine origin strain UK from calf with diarrhea |
| References |
Greenberg HB, et al. Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors. US Patent 4,571,385 dated Feb 18 1986
Midthun K, et al. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J. Virol. 53: 949-954, 1985. PubMed: 2983101
|
